In sub-Saharan Africa, more than 60% of all adults living with HIV in 2018 were women, according to the Joint United Nations Programme on HIV and AIDS (https://aidsinfo.unaids.org). Largely as a result of early access to HIV testing and antiretroviral treatment (ART) at antenatal clinics, women were the first to benefit from “Treat All” approaches to ART; with the introduction of Option B+ policies starting in 2011, all pregnant and breast-feeding women were offered immediate ART initiation and lifelong treatment, regardless of their CD4+ T-cell count or clinical staging. Women accounted for 67% of the 13.5 million adults receiving ART at the end of fiscal year 2018 in programs supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) globally (www.pepfar.gov).